Stem Cell Therapy Rx
How we got $1.2M
Based on typical figures for its industry (2022 Economic Census), not its own records.
What we know
Compared with similar businesses nearby
| Business | Est. revenue | Distance |
|---|---|---|
| Stem Cell Therapy Rx this business | $2.0M | — |
| TULSA PROFESSIONAL PSYCHOLOGY Tulsa · 5 employees | $1.1M | 0.0 mi |
| Neurometrics, Pllc Tulsa | $990K | 0.0 mi |
| Kirkpatrick Wellness Llc Tulsa | $990K | 0.0 mi |
| The Eye Institute: Neha Sangal, M.D. Tulsa | $990K | 0.0 mi |
| Tulsa Eye Clinic Tulsa | $990K | 0.0 mi |
| SOUTH TULSA OPTICAL, INC. Tulsa · 6 employees | $1.2M | 0.0 mi |
The full calculation
Figures are shown toward the upper part of their range rather than at its middle.
Brought up to date assuming revenue has grown 8% a year since 2020, when the PPP figures were reported; included above.
| Estimated value = EBITDA × typical sale multiple | $1.2M |
| Multiple for this size and industry | 3× |
| Value range | $380K – $1.8M |
This business has no PPP loan on record, so there is no business-specific data. The figures are the typical estimated revenue of Offices of other health practitioners businesses in our Oklahoma data: the middle value, with the range covering the middle half of those businesses. EBITDA applies the industry margin (19%). Treat these as a rough guide.
| Revenue range | $812K – $2.6M |
| EBITDA range | $158K – $508K |
| Industry (NAICS) | Offices of other health practitioners (6213) |
EBITDA margin: from IRS tax returns of S corporations in this industry (2019–2022), adjusted for company size: smaller companies typically run higher margins. EBITDA here is after owners' salaries.
Benchmarks: US Economic Census 2022, OK. These are statistical estimates, not reported financials. Listing details come from Overture Maps open data. Full methodology
2 locations
| 7146 S Braden Ave Ste 502 | Tulsa | This listing |
| 6711 S Yale Ave Ste 210 | Tulsa | View |
Revenue, profit and value are for the whole company.
Public records
Matched to this business by name and address from public government data; a match can occasionally be wrong.
About Stem Cell Therapy Rx
Stem Cell Therapy Rx is an offices of other health practitioners company in Tulsa, Oklahoma, in business since 2019. Its estimated annual revenue is about $2.0M, with roughly $386K of EBITDA. Its estimated business value is $1.2M (likely range $380K–$1.8M). It has 2 locations.
Common questions
- Who owns Stem Cell Therapy Rx?
- The owner of Stem Cell Therapy Rx isn't in public records we've found yet. If you own or run the business, you can add or correct its details on SeeBITDA.
- How much revenue does Stem Cell Therapy Rx make?
- SeeBITDA estimates Stem Cell Therapy Rx's annual revenue at about $2.0M (likely between $812K and $2.6M), based on public records such as its PPP loan and retirement-plan filings, brought up to 2026.
- What is Stem Cell Therapy Rx worth?
- About $1.2M, roughly 3× its estimated EBITDA of $386K, typical for a offices of other health practitioners company its size. Likely range: $380K–$1.8M.
- When was Stem Cell Therapy Rx founded?
- Stem Cell Therapy Rx has been in business since 2019.